Avoro Capital Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-416,230
| Closed | -$832K | – | 48 |
|
2017
Q2 | $832K | Sell |
416,230
-775,900
| -65% | -$1.55M | 0.11% | 38 |
|
2017
Q1 | $4.71M | Sell |
1,192,130
-263,926
| -18% | -$1.04M | 0.6% | 31 |
|
2016
Q4 | $7.14M | Sell |
1,456,056
-75,217
| -5% | -$369K | 1.44% | 22 |
|
2016
Q3 | $11.9M | Sell |
1,531,273
-124,001
| -7% | -$960K | 2.08% | 18 |
|
2016
Q2 | $9.27M | Buy |
1,655,274
+509,495
| +44% | +$2.85M | 2.06% | 16 |
|
2016
Q1 | $6.16M | Sell |
1,145,779
-800
| -0.1% | -$4.3K | 2.15% | 16 |
|
2015
Q4 | $9.99M | Sell |
1,146,579
-1,004,858
| -47% | -$8.75M | 3.44% | 10 |
|
2015
Q3 | $18.1M | Sell |
2,151,437
-35,083
| -2% | -$294K | 4.69% | 9 |
|
2015
Q2 | $38.5M | Sell |
2,186,520
-27,523
| -1% | -$485K | 10.61% | 2 |
|
2015
Q1 | $25.6M | Buy |
2,214,043
+1,303,943
| +143% | +$15.1M | 9.82% | 3 |
|
2014
Q4 | $9.17M | Buy |
+910,100
| New | +$9.17M | 6.21% | 6 |
|